The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Recent developments in nitric oxide donor drugs
Open accessAbstract
During the 1980s, the free radical, nitric oxide (NO), was discovered to be a crucial signalling molecule, with wide‐ranging functions in the cardiovascular, nervous and immune systems. Aside from providing a credible explanation for the actions of organic nitrates and sodium nitroprusside that have long been used in the treatment of angina and hypertensive crises respectively, the discovery generated great hopes for new NO‐based treatments for a wide variety of ailments. Decades later, however, we are still awaiting novel licensed agents in this arena, despite an enormous research effort to this end. This review explores some of the most promising recent advances in NO donor drug development and addresses the challenges associated with NO as a therapeutic agent. British Journal of Pharmacology(2007)151, 305–321; doi:10.1038/sj.bjp.0707224
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
Ludmer, P. L., Selwyn, A. P., Shook, T. L., Wayne, R. R., Mudge, G. H., Alexander, R. W., & Ganz, P. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610233151702 · Cited by 2,425
GRUPPOITALIANOPERLOSTUDIODELL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90232-1 · Cited by 1,118
A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans
Liu, L., Hausladen, A., Zeng, M., Que, L., Heitman, J., & Stamler, J. S. (2001) · Nature · doi:10.1038/35068596 · Cited by 913 · cited 2×
“…from S-nitrosothiols, including light, heat, transition metals, thiols, superoxide and enzymes such as xanthine oxidase (Trujillo et al., 1998), superoxide dismutase (Jourd’heuil et al., 1999), protein disulphide isomerase (Ramachandran et al., 2001) and various dehydrogenases (Liu et al., 2001).”
BackgroundCoxibs and Cardiovascular Disease
FitzGerald, G. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048288 · Cited by 899
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818 · cited 2×
“…dysfunction, occurring at a number of levels, including downregulation of eNOS expression and activity, uncoupling of NOS, scavenging of NO by oxygen-centred free radicals and decreased sensitivity of VSMCs to vasodilators, together with NO-independent alterations (Feletou and Vanhoutte, 2006).”
BackgroundDimmeler, S., Haendeler, J., Nehls, M., & Zeiher, A. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.601 · Cited by 806
Culotta, E., & Koshland, D. E. (1992) · Science · doi:10.1126/science.1361684 · Cited by 786
Maragos, C. M., Morley, D., Wink, D. A., Dunams, T. M., Saavedra, J. E., Hoffman, A., Bove, A. A., Isaac, L., Hrabie, J. A., & Keefer, L. K. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00115a013 · Cited by 722
Cited by
Plasma medicine: an introductory review
Kong, M. G., Kroesen, G., Morfill, G., Nosenko, T., Shimizu, T., van Dijk, J., & Zimmermann, J. L. (2009) · New Journal of Physics · doi:10.1088/1367-2630/11/11/115012 · Cited by 1,601
Graves, D. B. (2012) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/45/26/263001 · Cited by 1,518
BioMOFs: Metal–Organic Frameworks for Biological and Medical Applications
McKinlay, A. C., Morris, R. E., Horcajada, P., Férey, G., Gref, R., Couvreur, P., & Serre, C. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000048 · Cited by 1,256
Vatansever, F., de Melo, W. C. M. A., Avci, P., Vecchio, D., Sadasivam, M., Gupta, A., Chandran, R., Karimi, M., Parizotto, N. A., Yin, R., et al. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12026 · Cited by 1,127
Nitric oxide release: Part II. Therapeutic applications
Carpenter, A. W., & Schoenfisch, M. H. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15273h · Cited by 964
Metal–organic frameworks as potential drug carriers
Huxford, R. C., Della Rocca, J., & Lin, W. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.12.012 · Cited by 840
Destruction of Metal–Organic Frameworks: Positive and Negative Aspects of Stability and Lability
Feng, L., Wang, K.-Y., Day, G. S., Ryder, M. R., & Zhou, H.-C. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00722 · Cited by 662
Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials
Weinstain, R., Slanina, T., Kand, D., & Klán, P. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00663 · Cited by 642
Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
Andrabi, S. M., Sharma, N. S., Karan, A., Shahriar, S. M. S., Cordon, B., Ma, B., & Xie, J. (2023) · Advanced Science · doi:10.1002/advs.202303259 · Cited by 602
Strategies to increase nitric oxide signalling in cardiovascular disease
Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4623 · Cited by 576
The potential of nitric oxide releasing therapies as antimicrobial agents
Schairer, D. O., Chouake, J. S., Nosanchuk, J. D., & Friedman, A. J. (2012) · Virulence · doi:10.4161/viru.20328 · Cited by 573
McKinlay, A. C., Xiao, B., Wragg, D. S., Wheatley, P. S., Megson, I. L., & Morris, R. E. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801997r · Cited by 417
Self-citationNitric Oxide Donor-Based Cancer Therapy: Advances and Prospects
Huang, Z., Fu, J., & Zhang, Y. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01672 · Cited by 406
Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen
Pontel, L. B., Rosado, I. V., Burgos-Barragan, G., Garaycoechea, J. I., Yu, R., Arends, M. J., Chandrasekaran, G., Broecker, V., Wei, W., Liu, L., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.08.020 · Cited by 382
Nitric oxide release: Part III. Measurement and reporting
Coneski, P. N., & Schoenfisch, M. H. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15271a · Cited by 360
The Chemistry of Reticular Framework Nanoparticles: MOF, ZIF, and COF Materials
Ploetz, E., Engelke, H., Lächelt, U., & Wuttke, S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909062 · Cited by 350
Recent advances of discrete coordination complexes and coordination polymers in drug delivery
Ma, Z., & Moulton, B. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.01.031 · Cited by 310
Progress and Promise of Nitric Oxide‐Releasing Platforms
Yang, T., Zelikin, A. N., & Chandrawati, R. (2018) · Advanced Science · doi:10.1002/advs.201701043 · Cited by 309
Nitric Oxide Adsorption and Delivery in Flexible MIL-88(Fe) Metal–Organic Frameworks
McKinlay, A. C., Eubank, J. F., Wuttke, S., Xiao, B., Wheatley, P. S., Bazin, P., Lavalley, J.-C., Daturi, M., Vimont, A., De Weireld, G., et al. (2013) · Chemistry of Materials · doi:10.1021/cm304037x · Cited by 294
Testosterone: a vascular hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0582 · Cited by 293
Characterization of the Role of Nitric Oxide and Its Clinical Applications
Levine, A. B., Punihaole, D., & Levine, T. B. (2012) · Cardiology · doi:10.1159/000338150 · Cited by 265
Nitric Oxide: A Key Mediator of Biofilm Dispersal with Applications in Infectious Diseases
Barraud, N., Kelso, M., Rice, S., & Kjelleberg, S. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140905112822 · Cited by 255
Huang, S.-L., Kee, P. H., Kim, H., Moody, M. R., Chrzanowski, S. M., MacDonald, R. C., & McPherson, D. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.039 · Cited by 120
Nanocosmetics and Nanomedicines
(2011) · doi:10.1007/978-3-642-19792-5 · Cited by 116
Nitric Oxide Signaling and Regulation in the Cardiovascular System: Recent Advances
Carlström, M., Weitzberg, E., & Lundberg, J. O. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001060 · Cited by 103
Carreau, A., Kieda, C., & Grillon, C. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.08.011 · Cited by 88
“To mimic NO flux, we used two NO donors from the diazeniumdiolates family(also known as ‘NONOates’): spermine-NONOate and DPTA-NONOate, presenting a predictable rate of NO release [27].”
MethodLautner, G., Meyerhoff, M. E., & Schwendeman, S. P. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.056 · Cited by 70
Nitric Oxide-Releasing Electrospun Polymer Microfibers
Coneski, P. N., Nash, J. A., & Schoenfisch, M. H. (2011) · ACS Applied Materials & Interfaces · doi:10.1021/am101010e · Cited by 47
Ketchum, A. R., Kappler, M. P., Wu, J., Xi, C., & Meyerhoff, M. E. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb01664a · Cited by 28
Metadata
- Authors
- Miller, M. R., & Megson, I. L.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-06
- Volume
- 151
- Issue
- 3
- Pages
- 305-321
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1479760463
- Cited by
- 628
- References
- 199
- FWCI
- 16.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.